Lung cancer cell-derived EDA-containing fibronectin induces an inflammatory response from monocytes and promotes

Asif Amin1,2, Taseem A Mokhdomi1,3, Shoiab Bukhari1,4

  • 1Department of Biotechnology, University of Kashmir, Srinagar, India.

Insights

Lung cancer cells secrete fibronectin (EDAFN) that promotes tumor growth. This protein triggers inflammation and metastasis by interacting with monocytes and inducing epithelial-mesenchymal transition.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Tumor-associated macrophages (TAMs) promote tumor growth and metastasis through interactions with cancer cells.
  • Tumor cell-secreted proteins in the tumor microenvironment mediate this crucial cross-talk.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the cross-talk between lung cancer cells and TAMs.
  • To identify specific tumor cell-secreted proteins involved in promoting a pro-tumorigenic microenvironment.

Main Methods:

  • Immunoscreening of A549 lung carcinoma cell secretome using immunized Balb-c mice.
  • Serological examination and mass spectrometry to identify immunogenic proteins.
  • Analysis of EDAFN's interaction with THP-1 monocytes and its effect on NF-κB signaling and epithelial-mesenchymal transition.

Main Results:

  • Fibronectin containing the extra-domain A (EDAFN) was identified as a key immunogenic protein secreted by A549 cells.
  • A549-derived EDAFN activates Toll-like receptor 4 (TLR-4) on monocytes, initiating a pro-inflammatory response via NF-κB signaling.
  • EDAFN exhibits autocrine activity, inducing epithelial-mesenchymal transition and enhancing the metastatic potential of lung cancer cells.

Conclusions:

  • Lung cancer cells release EDAFN, which mediates cellular cross-talk with monocytes.
  • EDAFN contributes to establishing a pro-inflammatory and pro-metastatic tumor microenvironment, driving tumor progression.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K